Related Experiment Video
Updated: Jun 13, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Early life protein restriction alters dopamine circuitry
Z Vucetic1, K Totoki, H Schoch
1Department of Pharmacology, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Insights
Intrauterine growth retardation (IUGR) in mice alters dopamine systems, increasing ADHD and addiction risk. This IUGR model shows molecular and behavioral changes, offering insights into neurodevelopmental disorders.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Adverse prenatal environments, like intrauterine growth retardation (IUGR), are linked to neurodevelopmental issues.
- IUGR affects 10% of US infants and is a risk factor for ADHD, schizophrenia, and addiction.
Purpose of the Study:
- To investigate the effects of IUGR on dopamine-related gene expression, dopamine levels, and behavior in adult mice.
- To explore the role of Cdkn1c in IUGR-induced dopaminergic abnormalities.
Main Methods:
- A rodent model of IUGR was established using a protein-deficient diet during pregnancy and lactation.
- Dopamine-related gene expression, dopamine content, and behavioral tests were performed on adult offspring.
- DNA methylation and mRNA expression of Cdkn1c were analyzed.
Main Results:
- IUGR offspring exhibited significant overexpression of dopamine (DA) genes (TH, DAT) and increased DA in key brain regions.
- Increased TH-ir neurons in the VTA and elevated dopamine in the PFC were observed.
- Reduced Cdkn1c promoter methylation led to increased Cdkn1c mRNA expression, correlating with altered dopamine function and behavior.
Conclusions:
- IUGR induces significant molecular and behavioral abnormalities in the dopamine system in mice.
- This IUGR model provides a valuable tool for studying the mechanisms underlying neurobehavioral disorders like ADHD.
Abstract:
Adverse prenatal environment, such as intrauterine growth retardation (IUGR), increases the risk for negative neurobehavioral outcomes. IUGR, affecting approximately 10% of all US infants, is a known risk factor for attention deficit hyperactivity disorder (ADHD), schizophrenia spectrum disorders and addiction. Mouse dams were fed a protein deficient (8.5% protein) or isocaloric control (18% protein) diet through pregnancy and lactation (a well validated rodent model of IUGR). Dopamine-related gene expression, dopamine content and behavior were examined in adult offspring. IUGR offspring have six to eightfold over-expression of dopamine (DA)-related genes (tyrosine hydroxylase (TH) and dopamine transporter) in brain regions related to reward processing (ventral tegmental area (VTA), nucleus accumbens, prefrontal cortex (PFC)) and homeostatic control (hypothalamus), as well as increased number of TH-ir neurons in the VTA and increased dopamine in the PFC. Cyclin-dependent kinase inhibitor 1C (Cdkn1c) is critical for dopaminergic neuron development. Methylation of the promoter region of Cdkn1c was decreased by half and there was a resultant two to sevenfold increase in Cdkn1c mRNA expression across brain regions. IUGR animals demonstrated alterations in dopamine-dependent behaviors, including altered reward-processing, hyperactivity and exaggerated locomotor response to cocaine. These data describe significant dopamine-related molecular and behavioral abnormalities in a mouse model of IUGR. This animal model, with both face validity (behavior) and construct validity (link to IUGR and dopamine dysfunction) may prove useful in identifying underlying mechanisms linking IUGR and adverse neurobehavioral outcomes such as ADHD.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Drugs Affecting Neurotransmitter Synthesis
Neural Regulation

